ClassID:

96378

C07H15/00 - CPC Classification

Classification description:

Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

Sub-classes:
Recent Application in this class:
#1
20260110011
2026-04-23

PH- AND TEMPERATURE-STABLE ETHERIC SOPHOROLIPIDS AND THEIR USE

#2
20250170251
2025-05-29

PHOSPHOALKYL RIBOSE POLYMERS COMPRISING BIOLOGICALLY ACTIVE COMPOUNDS

#3
20250129401
2025-04-24

PH- AND TEMPERATURE-STABLE ETHERIC SOPHOROLIPIDS AND THEIR USE

#4
20240238322
2024-07-18

THERAPEUTIC AGENTS AND METHODS OF PRODUCING SAME

#5
20230017661
2023-01-19

COMPOSITIONS AND MODULAR NANO- AND MICROPARTICLES FOR THE DELIVERY OF VARIOUS AGENTS AND USE THEREOF

#6
20220025417
2022-01-27

Process for preparing sphingolipids

#7
20210386770
2021-12-16

Therapeutic agents and methods of producing same

#8
20200353094
2020-11-12

Phosphoalkyl ribose polymers comprising biologically active compounds

#9
20200016257
2020-01-16

Synthetic vaccines against serotype 2

#10
20190374559
2019-12-12

Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating induced inflammatory bowel diseases such as crohn's disease

#11
20190300917
2019-10-03

Process for preparing sphingolipids

#12
20190135848
2019-05-09

Amine solvate of sodium-glucose linked transporter inhibitor, and preparation method and application thereof

#13
20180369163
2018-12-27

Antibacterial S-heterosubstituted disulfides

#14
20170056337
2017-03-02

Antibacterial S-heterosubstituted disulfides

#15
20160340445
2016-11-24

Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating induced inflammatory bowel diseases such as crohn's disease

#16
20150266916
2015-09-24

Glucopyranosyl derivatives and their uses in medicine

#17
20150025039
2015-01-22

Antiviral phosphonate analogs

#18
20130237494
2013-09-12

Bone-targeting bisphosphonate duplex drugs

#19
20130178613
2013-07-11

Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes

#20
20130164319
2013-06-27

Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes

#21
20120269857
2012-10-25

Analogs of alpha galactosylceramide and uses thereof

#22
20120258043
2012-10-11

Linkable Lewis X Analogs

#23
20120190832
2012-07-26

LOW-MOLECULAR SERINE PROTEASES INHIBITORS COMPRISING POLYHYDROXY-ALKYL AND POLYHYDROXY-CYCLOALKYL RADICALS

#24
20120034269
2012-02-09

Analogs of alpha galactosylceramide and uses thereof

#25
20120003251
2012-01-05

Enhanced immunogenicity of tumor associated antigens by addition of αgal epitopes

#26
20110312905
2011-12-22

Stimulus-triggered prodrugs

#27
20110288053
2011-11-24

ANTIVIRAL PHOSPHONATE ANALOGS

#28
20110229409
2011-09-22

LINKABLE LEWIS X ANALOGS

#29
20110077302
2011-03-31

Enzymatic synthesis of sphingolipids

#30
20110071285
2011-03-24

LOW-MOLECULAR SERINE PROTEASES INHIBITORS COMPRISING POLYHYDROXY-ALKYL AND POLYHYDROXY-CYCLOALKYL RADICALS

#31
20110065801
2011-03-17

ENZYMATIC SYNTHESIS OF SPHINGOLIPIDS

#32
20100310633
2010-12-09

CHITINOSANASE

#33
20100228020
2010-09-09

Novel Chlorination Reagent and a Novel Process for Chlorination of Sugars Using Thionyl Chloride

#34
20100204337
2010-08-12

Antibacterial S-heterosubstituted disulfides

#35
20100104590
2010-04-29

α-galactosylceramide derivatives, pharmaceutically acceptable salts thereof, preparation method and pharmaceutical composition for the immune adjuvant containing the same as an active ingredient

#36
20100099641
2010-04-22

CRYSTALLINE FORM OF 1-CHOLORO-4-(BETA-D-GLUCOPYRANOS-1-YL)-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS

#37
20100035857
2010-02-11

ANTI-HYPERCHOLESTEROLEMIC COMPOUNDS

#38
20100009927
2010-01-14

Anti-Inflammatory and Anti-Allergy Extracts from Nettle

#39
20090298784
2009-12-03

Isolation and structure of turbostatins 1-4

#40
20090275535
2009-11-05

Antiviral phosphonate analogs

#41
20090275524
2009-11-05

NOVEL HYPOCHOLESTEROLEMIC COMPOUNDS

#42
20090239813
2009-09-24

Analogs of alpha galactosyceramide and uses thereof

#43
20090233875
2009-09-17

GLYCOLIPIDS AND ANALOGUES THEREOF AS ANTIGENS FOR NK T CELLS

#44
20090203926
2009-08-13

Process for selectively extracting procyanidins

#45
20090176717
2009-07-09

GALACTOSIDES AND THIODIGALACTOSIDES AS INHIBITORS OF PA-IL LECTIN FROM PSEUDOMONAS

#46
20090060930
2009-03-05

Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes

#47
20090048186
2009-02-19

Monosaccharide Derivatives as Anti-Inflammatory and/or Anti-Cancer Agents

#48
20090042819
2009-02-12

Organic nitric oxide donor salts of antimicrobial compounds, compositions and methods of use

#49
20090012013
2009-01-08

Steroid modified solatrioses

#50
20080300220
2008-12-04

Linkable Lewis X Analogs

#51
20080300196
2008-12-04

MONOSACCHARIDE DERIVATIVES

#52
20080299044
2008-12-04

Saccharide fluorescent substrates, preparation method and uses thereof

#53
20080274987
2008-11-06

Novel alpha glucosidase activator, pulicarside 1

#54
20080269144
2008-10-30

Synthesis of inhibitors of p90Rsk

#55
20080194801
2008-08-14

Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses

#56
20080146516
2008-06-19

C-glycosides, uses thereof

#57
20080114031
2008-05-15

MONOSACCHARIDE DERIVATIVES

#58
20080103295
2008-05-01

PROCESS FOR THE PREPARATION OF SUCROSE-6-ESTER BY ESTERIFICATION IN THE PRESENCE OF SOLID SUPERACID CATALYST

#59
20080076137
2008-03-27

Bioanalytic Systems and Methods

#60
20080015344
2008-01-17

Synthesis of monovalent and polyvalent arabinans and mannose-capped arabinans of the protective cell-wall coat of mycobacterium tuberculosis

#61
20070275909
2007-11-29

Hypocholesterolemic compounds

#62
20070275908
2007-11-29

Ganglioside compositions and methods of use

#63
20070260041
2007-11-08

Allylic disulfide rearrangement and desulfurization method for the preparation of allylic sulfides

#64
20070249544
2007-10-25

Crystalline form of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-(()-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments

#65
20070219144
2007-09-20

IMMUNOMODULATORY SACCHARIDE COMPOUNDS

#66
20070149477
2007-06-28

Immunomodulatory methods using oligosaccharides

#67
20070135358
2007-06-14

Steroid modified solatrioses

#68
20070078261
2007-04-05

Process for selectively extracting procyanidins

#69
20070037234
2007-02-15

Fluorogenic enzyme substrates and methods of preparation

#70
20060293250
2006-12-28

Crystalline sugar compositions and method of making

#71
20060242770
2006-11-02

Xyloglucan conjugates useful for modifying cellulosic textiles

#72
20060234961
2006-10-19

Anti bacterial compounds

#73
20060211856
2006-09-21

Glycolipids and analogues thereof as antigens for NK T cells

#74
20060116331
2006-06-01

Glycosylceramide analogues

#75
20060040893
2006-02-23

Immunomodulatory methods using oligosaccharides

#76
20050250708
2005-11-10

C-glycosides, uses thereof

#77
20050215513
2005-09-29

Antiviral phosphonate analogs

#78
20050148522
2005-07-07

Bifunctional antibiotics for targeting rRNA and resistance-causing enzymes and for inhibition of anthrax lethal factor

#79
20050090462
2005-04-28

Aminoglycoside antibiotics and methods of using same

#80
20050085632
2005-04-21

Method of removing isoflavones and phytates

#81
20050059817
2005-03-17

Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives

#82
20050004052
2005-01-06

Bifunctional antibiotics for targeting rRNA and resistance-causing enzymes